This spring, a group of commercial climbers plan to summit Everest in just a week by chemically boosting their ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for dialysis at Indiana University Health in Indianapolis discusses ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical officer for dialysis at Indiana University Health in Indianapolis, spoke on ...

In a German clinic, a climber undergoes pre-acclimatisation treatment ... high-altitude conditions in advance, the theory ...

A group of mountaineers plan to travel from Heathrow to the summit of Mount Everest and back in just seven days - a feat ...

A guiding service offers a pricey drug therapy (that's also illegal in professional sports) to get clients to the Everest ...

Akebia has since engaged with the FDA on potentially expanding vadadustat treatment to this patient population and has received feedback on a protocol submitted for a Phase 3 cardiovascular outcome ...

This spring, a group of commercial climbers plan to summit Everest in just a week by chemically boosting their ...

However, clinical treatment trials have so far been negative ... more information regarding temporal changes in, and origin of, erythropoietin levels. Our primary hypothesis was that high acute serum ...

That represents an uptick of 15% over the previous year's high of $17.3 billion ... 5–hydroxytryptamine 4 receptor agonist for the treatment of Alzheimer's disease. Biotech companies have ...

Objective To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin ... may be more efficacious when treatment is started at an early stage of ALS. A recent clinical trial ...